1. Aberrant replication licensing drives Copy Number Gains across species
- Author
-
Stavros Taraviras, Patroula Nathanailidou, Ourania Preza, Michalis Petropoulos, Iris Spiliopoulou-Sdougkou, Zoi Lygerou, Vladimir Benes, Eirini Kasselimi, Styliani Maxouri, and Ioanna Eleni Symeonidou
- Subjects
Whole genome sequencing ,DNA replication factor CDT1 ,Genetics ,Licensing factor ,Genetic heterogeneity ,Extrachromosomal DNA ,RAD52 ,biology.protein ,medicine ,Biology ,Amplicon ,Carcinogenesis ,medicine.disease_cause - Abstract
Copy Number Gains (CNGs) lead to genetic heterogeneity, driving evolution and carcinogenesis. The mechanisms promoting CNG formation however remain poorly characterized. We show that abnormal expression of the replication licensing factor Cdc18 in fission yeast, which leads to genome-wide re-replication, drives the formation of CNGs at different genomic loci, promoting the acquisition of new selectable traits. Whole genome sequencing reveals Mb long, primarily extrachromosomal amplicons. Genetic analysis shows that homology-mediated repair is required to resolve re-replication intermediates into heritable CNGs. Consistently, we show that in mammalian cells overexpression of CDC6 and/or CDT1 leads to CNGs and promotes drug resistance. In human cells, multiple repair pathways are activated upon rereplication and act antagonistically, with RAD52 promoting and 53BP1 inhibiting CNG formation. In tumours, CDT1 and/or CDC6 overexpression correlates with copy number gains genome-wide. We propose re-replication as an evolutionary-conserved driver of CNGs, highlighting a link between aberrant licensing, CNGs and cancer.
- Published
- 2020